Shaker Benjamin

CMO Shaker Benjamin purchases 18,448 shares of AGL; part of 2-insider cluster buy within 14 days as stock trades at $15.94, down 88.8% from 52-week high.

Shaker Benjamin, Chief Markets Officer, acquired 18,448 shares on 2026-03-09, bringing his total holdings to 1,379,774 shares (a 1.4% net increase). This purchase is part of a cluster pattern—2 other insiders also bought within the past 14 days—which may suggest coordinated confidence in the stock's prospects. However, context matters considerably: the stock is trading at $15.94, down 88.8% from its 52-week high of $142.00, and the company remains unprofitable with full-year net income of $-110,207,000.00 and annual revenue growth of -2.1%. Benjamin's same-ticker history shows mixed results: his 2025-03-14 buy delivered +40.2% in 30 days but then declined -45.9% over 90 days, while his 2024-03-14 buy lost -5.4% initially but recovered to +31.6% at the 90-day mark. The insider cluster buy is noteworthy, but the fundamental backdrop—persistent losses and shrinking revenue—combined with the stock's extreme drawdown from its recent peak suggests investors should examine whether this purchasing pattern reflects opportunity recognition or a response to distressed valuation.

Shaker Benjamin (CMO) buys 500,000 AGL shares at $0.60; stock down -90.0% from 52-week high, company unprofitable.

Shaker Benjamin, Chief Markets Officer of Agilon Health, purchased 500,000 shares at $0.60 on 2026-03-02, increasing his holdings to 1,367,674 shares (+57.6%). The timing is notable: at the transaction price of $0.60, the stock trades far below recent levels, and the current price of $14.18 reflects a -90.0% decline from the 52-week high of $142.00. His prior trades at AGL show mixed timing results—a buy on 2025-03-14 experienced a 90d return of -45.9%, while an earlier buy on 2024-03-14 eventually returned +31.6% over 90 days. The company reported $1.4B in latest quarterly revenue but posted negative net income of $-110.2M and remains unprofitable on a full-year basis, with revenue declining -2.1% year-over-year. The purchase occurs in an environment of severe stock-price deterioration and fundamental operational losses, making this a material but mixed-signal event that requires scrutiny of whether this reflects opportunity recognition or reflects other motivations not apparent from price action alone.

CMO Shaker Benjamin purchases 11,786 AGL shares; cluster buy pattern with 2 other insiders in past 14 days

Shaker Benjamin, Chief Markets Officer, acquired 11,786 shares on 2025-03-14, bringing his holdings to 457,058 shares—a 2.6% increase from 445,272 shares held previously. This open-market purchase occurs as part of a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated or contemporaneous conviction at current valuations. The stock has rallied 26.3% over the past 30 days and 121.5% over 90 days, climbing from the 52-week low but currently trading at $108.00—42.6% below its 52-week high of $188.00. Benjamin's prior buy at this ticker on 2024-03-14 delivered a 90-day return of +31.6%, demonstrating a pattern of well-timed accumulation at this company. However, context matters: Agilon Health remains unprofitable (net income $-117,615,000 in the latest quarter) despite strong revenue growth of 40.4% annually, and the company carries a substantial $44.5B market cap against negative earnings.